{
  "figure_1": "Multiple-Dose Study Design in Part A. IV, intravenous; TIW, three times a week",
  "figure_2": "Mean Difelikefalin Concentrations in NDD Subjects with Varying Degrees of (a, b) Renal Impairment and (c) HD Subjects*. *No PK assessments were performed between 48 and 92Â h. Concentrations from day 1 to day 8 (linear scale) in the PK population. For the calculation of means, individual concentration values that were below the limit of quantitation (BLQ of 0.100 ng/mL) were treated as zero. IV bolus was administered after each dialysis session; dialysis occurred on days 1, 3, 5, and 8. PK, pharmacokinetic; SD, standard deviation"
}